本文選題：同濟堂連鎖藥房 + 物流配送模式　； 參考：《濟南大學》2014年碩士論文

【摘要】：1995年5月，深圳中聯(lián)廣深醫(yī)藥(集團)股份有限公司成立的深圳中聯(lián)大藥房開啟了我國藥品零售連鎖經(jīng)營的新模式�！短幏剿幒头翘幏椒诸惞芾磙k法》的實施、國家取消對跨省經(jīng)營連鎖藥店的限制和新醫(yī)改方案的落實等一系列政策的鼓勵和支持，極大地推動了我國藥品零售連鎖經(jīng)營模式跨區(qū)域的擴張。連鎖經(jīng)營模式深受市場和企業(yè)的青睞主要得益于它標準化的管理、專業(yè)化的分工、易復制性和所帶來的規(guī)模效益等優(yōu)勢。零售連鎖企業(yè)能夠實現(xiàn)規(guī)�；芾砗拖M分散性統(tǒng)一的背后，是物流配送的巨大支持。物流配送直接關系到企業(yè)商品的供應能力、運營成本高低、消費者的滿意度等多方面，被越來越多企業(yè)作為其核心競爭力的重要組成部分。而物流配送對于藥品零售連鎖企業(yè)來說有著更重要的影響。 藥品使用直接關系著人們的肌體健康和生命安全。藥品質量的嚴格性、限時性、專屬性等特征決定了藥品配送的專業(yè)化、高標準和高安全性。而且藥品種類繁多，一些病癥的突發(fā)性、多樣性及患者體質的差異等使藥品配送表現(xiàn)為多批次、小批量。為了更好了保證藥品在整個配送作業(yè)的過程中的質量安全，國家出臺了一系列的規(guī)范條例，如《藥品物流服務規(guī)范》《互聯(lián)網(wǎng)藥品交易服務審批暫行規(guī)定》《關于加強互聯(lián)網(wǎng)藥品管理銷售的通知》等，，盡可能降低配送作業(yè)對藥品品質的影響以及一些特殊藥品在配送過程中可能產(chǎn)生危害。 本文以同濟堂連鎖藥房物流配送模式為研究對象，基于對連鎖經(jīng)營、物流配送等相關理論的分析，結合同濟堂連鎖藥房發(fā)展的內(nèi)外部環(huán)境及其實施物流戰(zhàn)略，在對不同配送模式詳細分析的基礎上，綜合考慮各方面影響因素，通過矩陣圖和層次分析法構建模型，設計出契合同濟堂連鎖藥房發(fā)展的物流配送模式。期望不論是在理論還是現(xiàn)實中，能夠為藥品連鎖行業(yè)物流配送模式的選擇和決策提供一定的支持和參考價值。
[Abstract]:In May 1995, Shenzhen Zhonglian Guangshen Pharmaceutical (Group) Co., Ltd. was established in Shenzhen Zhonglian University Pharmacy, which opened a new mode of drug retail chain operation in China. A series of policies, such as the cancellation of restrictions on inter-provincial chain pharmacies and the implementation of the new medical reform scheme, have greatly promoted the cross-regional expansion of the drug retail chain operation model in China. The chain management model is favored by the market and enterprises mainly thanks to its standardized management, specialized division of labor, easy replication and the advantages of scale benefits. The retail chain enterprise can realize the scale management and the consumption dispersal unification behind, is the logistics distribution huge support. Logistics distribution is directly related to the supply ability of enterprises, operating costs, consumer satisfaction, and so on, and is regarded as an important part of its core competitiveness by more and more enterprises. Logistics distribution has a more important impact on drug retail chain enterprises. Drug use is directly related to human body health and life safety. The specialty, high standard and high safety of drug delivery are determined by the strict, limited and exclusive characteristics of drug quality. The variety of drugs, the sudden onset of some diseases, the diversity and the difference of patients' physique make the drug delivery in many batches and small batches. In order to better ensure the quality and safety of drugs throughout the distribution process, the state has issued a series of regulations and regulations. For example, the "Drug Logistics Service Standard", the "interim provisions on the approval of Internet Drug Trading Services", the "notice on strengthening the Management and sales of drugs on the Internet", and so on, To minimize the impact of distribution operations on drug quality and some special drugs in the distribution process may cause harm. Based on the analysis of chain management, logistics distribution and other related theories, this paper combines the internal and external environment of the development of Tongjitang chain pharmacy and the implementation of logistics strategy, taking Tongjitang chain pharmacy as the research object, and based on the analysis of chain management, logistics distribution and other related theories. On the basis of detailed analysis of different distribution modes and considering various factors comprehensively, the model was constructed by matrix diagram and analytic hierarchy process (AHP), and a logistics distribution model suitable for the development of Tongjidang chain pharmacy was designed. It is expected that both in theory and in reality, it can provide certain support and reference value for the choice and decision of logistics distribution mode in pharmaceutical chain industry.
【學位授予單位】：濟南大學
【學位級別】：碩士
【學位授予年份】：2014
【分類號】：F721.7;F252

【參考文獻】

相關期刊論文 前5條

1 黃毅;;廣西醫(yī)藥連鎖企業(yè)的物流配送模式研究[J];廣西大學學報(哲學社會科學版);2009年06期

2 ;處方藥與非處方藥分類管理辦法[J];中華人民共和國國務院公報;1999年29期

3 李軍;徐懷伏;;醫(yī)藥第三終端消費者研究[J];現(xiàn)代商貿(mào)工業(yè);2011年24期

4 王軍;徐國;;尋根:追蹤一個行業(yè)的十年軌跡[J];中國藥店;2009年07期

5 張夢童;;可變數(shù)據(jù) 給我力量[J];印刷技術;2013年13期

本文編號：2073114